Therefore, anti-EGFR/HGNs will be selectively uptaken by cervical cancer cells and induce their apoptosis, as a result reducing nonspecific injury to normal cells when combined with radiotherapy. The gene discussed is EGFR; the disease is cervical carcinoma.